Holen Sie sich die Stockscreener-App
484.86
1.78%
8.50
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt UTHR?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$476.36
Offen:
$479.62
24-Stunden-Volumen:
328.10K
Relative Volume:
0.55
Marktkapitalisierung:
$20.88B
Einnahmen:
$3.08B
Nettoeinkommen (Verlust:
$1.24B
KGV:
18.93
EPS:
25.6108
Netto-Cashflow:
$1.07B
1W Leistung:
+0.81%
1M Leistung:
+6.81%
6M Leistung:
+72.33%
1J Leistung:
+33.85%
1-Tages-Spanne:
$477.54
$486.23
1-Wochen-Bereich:
$474.59
$489.99
52-Wochen-Spanne:
$266.98
$492.62
United Therapeutics Corp Stock (UTHR) Company Profile
Firmenname
United Therapeutics Corp
Sektor
Telefon
(301) 608-9292
Adresse
1000 SPRING ST, SILVER SPRING, MD
Vergleichen Sie UTHR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
484.86 | 20.51B | 3.08B | 1.24B | 1.07B | 25.61 |
|
ZTS
Zoetis Inc
|
118.07 | 51.01B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.37 | 45.05B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.80 | 32.77B | 16.70B | -157.13M | 1.19B | -0.1446 |
United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Underweight |
| 2025-09-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-06-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-04-21 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-07-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | Hochstufung | Goldman | Sell → Neutral |
| 2024-02-05 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-06 | Eingeleitet | UBS | Buy |
| 2022-12-05 | Eingeleitet | Goldman | Sell |
| 2022-10-11 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-09-20 | Bestätigt | BofA Securities | Underperform |
| 2022-09-19 | Fortgesetzt | Wedbush | Outperform |
| 2022-02-11 | Eingeleitet | BTIG Research | Neutral |
| 2021-07-14 | Hochstufung | Argus | Hold → Buy |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-02-01 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | Fortgesetzt | JP Morgan | Overweight |
| 2020-06-25 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-03-10 | Hochstufung | Jefferies | Hold → Buy |
| 2020-02-27 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-01-31 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-12-03 | Eingeleitet | BofA/Merrill | Underperform |
| 2019-08-01 | Hochstufung | Jefferies | Underperform → Hold |
| 2019-08-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-09 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | Hochstufung | Standpoint Research | Hold → Buy |
| 2018-08-08 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | Bestätigt | Barclays | Underweight |
| 2018-01-18 | Fortgesetzt | Credit Suisse | Underperform |
| 2017-12-27 | Bestätigt | Wedbush | Outperform |
| 2017-04-27 | Bestätigt | Wedbush | Outperform |
| 2017-03-30 | Eingeleitet | UBS | Sell |
| 2017-03-16 | Eingeleitet | Credit Suisse | Underperform |
Alle ansehen
United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten
Insider Sell: Nilda Mesa Sells Shares of United Therapeutics Cor - GuruFocus
Why a $27 Million Buy Signals New Confidence in Weatherford Stock - The Motley Fool
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term - Yahoo Finance
Chmn Rothblatt Files To Sell 4,000 Of United Therapeutics Corp [UTHR] - TradingView
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 4,000 Shares - MarketBeat
Rothblatt, United Therapeutics CEO, sells $3.8m in UTHR stock By Investing.com - Investing.com India
Rothblatt, United Therapeutics CEO, sells $3.8m in UTHR stock - Investing.com
United Therapeutics Insider Sold Shares Worth $3,870,056, According to a Recent SEC Filing - marketscreener.com
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView
Chmn Rothblatt Sells 8,000 ($3.9M) Of United Therapeutics Corp [UTHR] - TradingView
Invesco Ltd. Grows Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corporation $UTHR Shares Acquired by Marshall Wace LLP - MarketBeat
United Therapeutics Corporation $UTHR Position Cut by Schroder Investment Management Group - MarketBeat
Epoch Investment Partners Inc. Has $83.76 Million Holdings in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (UTHR): Revisiting Valuation After Q3 2025 Growth, Strong 2027 Guidance and Rising Institutional Interest - simplywall.st
UTHR SEC FilingsUnited Therapeutics Corp. 10-K, 10-Q, 8-K Forms - Stock Titan
Insider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 22,500 Shares of Stock - MarketBeat
State Board of Administration of Florida Retirement System Has $12.22 Million Position in United Therapeutics Corporation $UTHR - MarketBeat
Russell Investments Group Ltd. Lowers Stock Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Executives Sell Shares Under 10b5-1 Trading Plans - TradingView
Korea Investment CORP Sells 18,300 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Pres Benkowitz Files To Sell 112,500 Of United Therapeutics Corp [UTHR] - TradingView
United Therapeutics Corporation $UTHR Shares Acquired by Hsbc Holdings PLC - MarketBeat
Virtus Investment Advisers LLC Boosts Stake in United Therapeutics Corporation $UTHR - MarketBeat
XTX Topco Ltd Has $1.39 Million Holdings in United Therapeutics Corporation $UTHR - MarketBeat
1,280 Shares in United Therapeutics Corporation $UTHR Purchased by Inceptionr LLC - MarketBeat
Charles Schwab Investment Management Inc. Decreases Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Is United Therapeutics Still a Hidden Gem After 34.9% Share Price Surge in 2025? - simplywall.st
Vinva Investment Management Ltd Raises Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
What is the fair value of United Therapeutics Corporation stock nowEarnings Overview Report & High Yield Equity Trading Tips - moha.gov.vn
Insider Selling: United Therapeutics (NASDAQ:UTHR) EVP Sells 11,000 Shares of Stock - MarketBeat
United Therapeutics Corporation $UTHR Shares Bought by Legal & General Group Plc - MarketBeat
United Therapeutics Executives Sell Shares Worth Over $15 Million - TradingView
[Form 4] UNITED THERAPEUTICS Corp Insider Trading Activity - Stock Titan
Journey Strategic Wealth LLC Takes Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (NASDAQ:UTHR) Stock Unloaded Rep. Lisa C. McClain - MarketBeat
Chmn Rothblatt Sells 8,000 ($3.8M) Of United Therapeutics Corp [UTHR] - TradingView
United Therapeutics stock hits all-time high at 485.43 USD - Investing.com
Vanguard Group Inc. Sells 8,287 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Prudential PLC Raises Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Has $12.56 Million Stock Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corporation (UTHR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Heatmap analysis for United Therapeutics Corporation and competitorsJuly 2025 Highlights & Weekly Breakout Opportunity Watchlist - newser.com
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock - Yahoo Finance
Why United Therapeutics Corporation stock is trending among retail tradersMarket Trend Review & Precise Buy Zone Tips - newser.com
Jefferies reiterates Buy rating on United Therapeutics stock, cites strong growth By Investing.com - Investing.com South Africa
How United Therapeutics Corporation (UTH) stock trades after earningsBear Alert & AI Powered Buy/Sell Recommendations - newser.com
Understanding United Therapeutics Corporation’s price movementMarket Activity Summary & Daily Technical Stock Forecast Reports - newser.com
Jefferies reiterates Buy rating on United Therapeutics stock, cites strong growth - Investing.com
James Edgemond Sells 21,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
How United Therapeutics Corporation stock benefits from global expansionEarnings Trend Report & Trade Opportunity Analysis Reports - newser.com
Finanzdaten der United Therapeutics Corp-Aktie (UTHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
4.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):